GSTP1 and prostate cancer: Vera Hauptstock et al. demonstrate that hypermethylation of the GSTP1 promoter in prostate cancer correlates with repressive histone patterns and that depsipeptide reverses DNA methylation and reduces repressive histone modifications for epigenetic therapy of prostate cancer [16].